UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Baseline Cellular HIV DNA Load Predicts HIV DNA Decline and Residual HIV Plasma Levels during Effective Antiretroviral Therapy

Journal of Clinical Microbiology, 2012-02, Vol.50 (2), p.258-263

2012

Volltextzugriff (PDF)

Vaccine against SARS-CoV-2 in previously infected health care workers

EBioMedicine, 2021-09, Vol.71, p.103556-103556, Article 103556

Parisi, Saverio Giuseppe

2021

Volltextzugriff (PDF)

Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection

International journal of infectious diseases, 2021-07, Vol.108, p.176-178

2021

Volltextzugriff (PDF)

Measurement of ribavirin and evaluation of its stability in human plasma by high-performance liquid chromatography with UV detection

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007-09, Vol.856 (1), p.358-364

2007

Volltextzugriff (PDF)

Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose

International journal of infectious diseases, 2021-11, Vol.112, p.40-44

2021

Volltextzugriff (PDF)

Patterns of Transmitted Drug Resistance Mutations and HIV-1 Subtype Dynamics in ART-Naïve Individuals in Veneto, Italy, from 2017 to 2024

Viruses, 2024-08, Vol.16 (9), p.1393

2024

Volltextzugriff (PDF)

Resistance in Pseudomonas aeruginosa: A Narrative Review of Antibiogram Interpretation and Emerging Treatments

Antibiotics (Basel), 2023-11, Vol.12 (11), p.1621

2023

Volltextzugriff (PDF)

HBcAb Positivity as a Risk Factor for Missing HIV RNA Undetectability after the 3TC+DTG Switch

Viruses, 2024-02, Vol.16 (3), p.348

2024

Volltextzugriff (PDF)

HIV Replication at Low Copy Number and its Correlation with the HIV Reservoir: A Clinical Perspective

Current HIV research, 2015-05, Vol.13 (3), p.250-257

2015

Volltextzugriff (PDF)

Predicting Factors of Plasma HIV RNA Undetectability after Switching to Co-Formulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Experienced HIV-1 Patients: A Multicenter Study

Viruses, 2023-08, Vol.15 (8), p.1727

2023

Volltextzugriff (PDF)

Changing Prevalence of AIDS and Non-AIDS-Defining Cancers in an Incident Cohort of People Living with HIV over 28 Years

Cancers, 2023-12, Vol.16 (1), p.70

2023

Volltextzugriff (PDF)

HIV tropism switch in archived DNA of HIV-HCV subjects successfully treated with direct-acting antivirals for HCV infection

Scientific reports, 2021-04, Vol.11 (1), p.9274-9274, Article 9274

2021

Volltextzugriff (PDF)

Infectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients

PloS one, 2017-05, Vol.12 (5), p.e0176881-e0176881

2017

Volltextzugriff (PDF)

Oral and anal high-risk human papilloma virus infection in HIV-positive men who have sex with men over a 24-month longitudinal study: complexity and vaccine implications

BMC public health, 2019-05, Vol.19 (1), p.645-645, Article 645

2019

Volltextzugriff (PDF)

BNT162b2 SARS-CoV-2 Vaccination Elicits High Titers of Neutralizing Antibodies to Both B.1 and P.1 Variants in Previously Infected and Uninfected Subjects

Life (Basel, Switzerland), 2021-08, Vol.11 (9), p.896

2021

Volltextzugriff (PDF)

Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: a 24-month longitudinal study

BMC infectious diseases, 2018-12, Vol.18 (1), p.683-683, Article 683

2018

Volltextzugriff (PDF)

Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach

PloS one, 2019-03, Vol.14 (3), p.e0213160-e0213160

2019

Volltextzugriff (PDF)

What do We Know about Cryptic Aspergillosis?

Microorganisms (Basel), 2024-05, Vol.12 (5), p.886

2024

Volltextzugriff (PDF)

HBV in Italian Women's Jail: An Underestimated Problem?

Journal of clinical medicine, 2024-02, Vol.13 (5), p.1398

2024

Volltextzugriff (PDF)

Humoral Response after Two Doses of BNT162b2 mRNA Vaccine Has a Role in Predicting Response after Three Doses That Is Related to Plasma HIV Viremia and Nadir CD4+ Cell Count in HIV-Positive Patients

Vaccines (Basel), 2022-12, Vol.11 (1), p.82

2022

Volltextzugriff (PDF)

SARS-CoV-2 Neutralizing Antibodies to B.1 and to BA.5 Variant after Booster Dose of BNT162b2 Vaccine in HIV Patients COVID-Naïve and on Successful Antiretroviral Therapy

Vaccines (Basel), 2023-04, Vol.11 (4), p.871

2023

Volltextzugriff (PDF)

Association between Cellular Human Immunodeficiency Virus DNA Level and Immunological Parameters in Patients with Undetectable Plasma Viremia Level during Highly Active Antiretroviral Therapy

Journal of Clinical Microbiology, 2005-12, Vol.43 (12), p.6183-6185

2005

Volltextzugriff (PDF)

Long-Term Longitudinal Analysis of Neutralizing Antibody Response to Three Vaccine Doses in a Real-Life Setting of Previously SARS-CoV-2 Infected Healthcare Workers: A Model for Predicting Response to Further Vaccine Doses

Vaccines (Basel), 2022-08, Vol.10 (8), p.1237

2022

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(84)

Publikationsform

Sprache

Englisch
(89)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(5)
Viruses
(5)
Aids
(4)
Bmc Infectious Diseases
(4)
International Journal Of Infectious Diseases
(4)
Journal Of Medical Virology
(4)
The New Microbiologica
(3)
Vaccines
(3)
Antibiotics
(2)
Ebiomedicine
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Baseline Cellular HIV DNA Load Predicts HIV DNA Decline and Residual HIV Plasma Levels during Effective Antiretroviral Therapy

Vaccine against SARS-CoV-2 in previously infected health care workers

Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection

Measurement of ribavirin and evaluation of its stability in human plasma by high-performance liquid chromatography with UV detection

Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose

Patterns of Transmitted Drug Resistance Mutations and HIV-1 Subtype Dynamics in ART-Naïve Individuals in Veneto, Italy, from 2017 to 2024

Resistance in Pseudomonas aeruginosa: A Narrative Review of Antibiogram Interpretation and Emerging Treatments

HBcAb Positivity as a Risk Factor for Missing HIV RNA Undetectability after the 3TC+DTG Switch

HIV Replication at Low Copy Number and its Correlation with the HIV Reservoir: A Clinical Perspective

Predicting Factors of Plasma HIV RNA Undetectability after Switching to Co-Formulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Experienced HIV-1 Patients: A Multicenter Study

Changing Prevalence of AIDS and Non-AIDS-Defining Cancers in an Incident Cohort of People Living with HIV over 28 Years

HIV tropism switch in archived DNA of HIV-HCV subjects successfully treated with direct-acting antivirals for HCV infection

Infectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients

Role of HBcAb Positivity in Increase of HIV-RNA Detectability after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Months 48 Results of a Multicenter Italian Cohort

Oral and anal high-risk human papilloma virus infection in HIV-positive men who have sex with men over a 24-month longitudinal study: complexity and vaccine implications

BNT162b2 SARS-CoV-2 Vaccination Elicits High Titers of Neutralizing Antibodies to Both B.1 and P.1 Variants in Previously Infected and Uninfected Subjects

Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: a 24-month longitudinal study

Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach

What do We Know about Cryptic Aspergillosis?

HBV in Italian Women's Jail: An Underestimated Problem?

Humoral Response after Two Doses of BNT162b2 mRNA Vaccine Has a Role in Predicting Response after Three Doses That Is Related to Plasma HIV Viremia and Nadir CD4+ Cell Count in HIV-Positive Patients

Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19

SARS-CoV-2 Neutralizing Antibodies to B.1 and to BA.5 Variant after Booster Dose of BNT162b2 Vaccine in HIV Patients COVID-Naïve and on Successful Antiretroviral Therapy

Association between Cellular Human Immunodeficiency Virus DNA Level and Immunological Parameters in Patients with Undetectable Plasma Viremia Level during Highly Active Antiretroviral Therapy

Long-Term Longitudinal Analysis of Neutralizing Antibody Response to Three Vaccine Doses in a Real-Life Setting of Previously SARS-CoV-2 Infected Healthcare Workers: A Model for Predicting Response to Further Vaccine Doses

Suchergebnisse filtern